R E G I O N A L C H E C K - U P

Dubai skyline silhouette at sunset , seen from the Arabian Desert appropriate prophylaxis in the Middle Eastern region . The study investigated more than 2,000 patients and found that patient compliance to VTE guideline-based thromboprophylaxis was as low as 40.1 % in medical patients and 36.4 % in surgical patients , indicating a large unmet need for atrisk patients across the region .

Bernard Ross , CEO at Sky Medical Technology

Understanding the risks

of blood-clot related conditions and the subsequent risks is low . In fact , a 2023 survey further revealed that only 18.6 % of Saudi Arabian ’ s were aware of DVT . What ’ s more , the majority of respondents believed that having a blood clot was not considered a medical emergency .

Although globally prevalent and dangerous , VTE is entirely preventable particularly in the hospital setting . Through thromboprophylaxis , at-risk hospitalised patients can be monitored and prescribed preventative methods to eliminate the chance of developing blood clots whilst recovering from other conditions in hospital . However , the management of VTE is considered to lack standardisation in parts of the Middle East , with significant variability in the implementation of thromboprophylactic methods in the nation ’ s hospitals .

Moreover , a Middle Eastern ( AVAIL ME ) study explored patients at risk for VTE to identify the rate of patients receiving

In parts of the Middle East , VTE prevention is largely provided via pharmacological thromboprophylaxis like oral anticoagulants . These are prescribed to patients to inhibit the group of blood proteins that are responsible for clotting , thinning the blood and preventing clots altogether . However , a 2023 study exploring the clinical efficacy of VTE management in Saudi Arabian hospitals revealed that anticoagulants were associated with a higher risk of VTE recurrence . Meanwhile , a lack of adherence to anticoagulation treatment after discharge has also been observed .

In some cases , anticoagulant strategies are deemed unfit for patients – for instance , those recovering from stroke or pregnant patients often cannot be prescribed pharmacological prophylaxis as it increases the risk of extracranial bleeding and complications related to haemorrhage .

www . intelligenthealth . tech 45